Mode
Text Size
Log in / Sign up
N/A N=53 Prevention

Motivating a Spectrum of Cancer Patients to Quit Smoking

Cancer · Smoking

Enrolled (actual)
53
Serious AEs
Results posted
Apr 2023
Primary outcome: Primary: Number of Participants Who Consent to Participate in the Study- Feasibility — 53 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Self-help Materials (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Primary completion
Apr 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Who Consent to Participate in the Study- Feasibility
53
PRIMARY
Number of Participants That Complete 1-week Follow-up Assessments - Feasibility
46
PRIMARY
Number of Participants That Complete 1 Month Follow-up Assessments - Feasibility
44
PRIMARY
Number of Participants Who Read the Booklet - Demand - 1 Week Post Treatment
38
PRIMARY
Number of Participants Who Read the Booklet - Demand - 1 Month Post Treatment
42
PRIMARY
Acceptability
24.43
SECONDARY
Motivation to Quit Smoking Assessed With the Contemplation Ladder
7.35; 7.58; 7.79
SECONDARY
Motivation to Quit Smoking Assessed With the Short Form of the Smoking Abstinence-related Motivational Engagement (ARME).
23.41; 24.59; 24.11
SECONDARY
Participants Change in Motivation - Action Stage
4; 6; 12
SECONDARY
Motivation to Quit Smoking Assessed With the Number of Visits to the Study Website
1
SECONDARY
Motivation to Quit Smoking Assessed by Contact With the Tobacco Treatment Specialist - 1 Week
2; 10
SECONDARY
Motivation to Quit Smoking Assessed by Contact With the Tobacco Treatment Specialist - 1 Month
3; 10
SECONDARY
Participants That Had a Quit Attempt - 1 Week
15
SECONDARY
Participants That Had a Quit Attempt - 1 Month
25
SECONDARY
Motivation to Quit Smoking Assessed With the Number of Quit Attempts - 1 Month
6.74
SECONDARY
Number of Participants Reporting 7-day Point Prevalence Abstinence
6
SECONDARY
Number of Participants Reporting 30-day Point Prevalence Abstinence
12

Summary

This study will assess feasibility and acceptability of an intervention designed to increase smoking cessation motivation among patients with a cancer not widely known to be smoking related.

Eligibility Criteria

Inclusion Criteria

  • Smoking at least 1 cigarette in previous 30 days
  • Diagnosis of breast, colorectal, gynecological, skin melanoma, or bladder cancer within the last 6 months
  • Able to read/write English
  • Able to give informed consent
  • Not currently enrolled in a smoking cessation program

Exclusion Criteria

  • Having distant metastases
  • Male patients with breast cancer
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04914000). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search